Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Maher

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2019
Gene Fusion Discovery with INTEGRATEJin Zhang, Christopher A Maher
NAR Cancer|June 5, 2023
CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteinsGhofran Othoum, Christopher A Maher
Drug Discovery Today|October 24, 2015
Clonotyping for precision oncologyHa X Dang, Christopher A Maher
Cell|January 24, 2012
Chromothripsis and human disease: piecing together the shattering processChristopher A Maher, Richard K Wilson
Scientific Reports|December 21, 2017
INTEGRATE-Vis: a tool for comprehensive gene fusion visualizationJin Zhang, Teng Gao, Christopher A Maher
Bioinformatics (Oxford, England)|November 1, 2016
INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discoveryJin Zhang, Elaine R Mardis, Christopher A Maher
Bioinformatics (Oxford, England)|August 16, 2011
ChimeraScan: a tool for identifying chimeric transcription in sequencing dataMatthew K Iyer, Arul M Chinnaiyan, Christopher A Maher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Common gene rearrangements in prostate cancerMark A Rubin, Christopher A Maher, Arul M Chinnaiyan
Current Drug Targets|February 16, 2013
Recurrent rearrangements in prostate cancer: causes and therapeutic potentialNicole M White, Felix Y Feng, Christopher A Maher
Biology Open|December 9, 2025
Methylation-based signature to distinguish indolent and aggressive prostate cancerMuheng Liao, Jace Webster, Amy Ly, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2019
Gene Fusion Discovery with INTEGRATEJin Zhang, Christopher A Maher
NAR Cancer|June 5, 2023
CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteinsGhofran Othoum, Christopher A Maher
Drug Discovery Today|October 24, 2015
Clonotyping for precision oncologyHa X Dang, Christopher A Maher
Cell|January 24, 2012
Chromothripsis and human disease: piecing together the shattering processChristopher A Maher, Richard K Wilson
Scientific Reports|December 21, 2017
INTEGRATE-Vis: a tool for comprehensive gene fusion visualizationJin Zhang, Teng Gao, Christopher A Maher
Bioinformatics (Oxford, England)|November 1, 2016
INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discoveryJin Zhang, Elaine R Mardis, Christopher A Maher
Bioinformatics (Oxford, England)|August 16, 2011
ChimeraScan: a tool for identifying chimeric transcription in sequencing dataMatthew K Iyer, Arul M Chinnaiyan, Christopher A Maher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Common gene rearrangements in prostate cancerMark A Rubin, Christopher A Maher, Arul M Chinnaiyan
Current Drug Targets|February 16, 2013
Recurrent rearrangements in prostate cancer: causes and therapeutic potentialNicole M White, Felix Y Feng, Christopher A Maher
Biology Open|December 9, 2025
Methylation-based signature to distinguish indolent and aggressive prostate cancerMuheng Liao, Jace Webster, Amy Ly, et al.
Pageof 11